Table 3: Patients characteristics classified by threshold of BP normality by measurement methods (AH: arterial hypertension).

Uncontrolled AHMasked AHWhite-coat AHControlled AHP

Age 5 5 . 3 0 ± 1 2 . 6 5 5 0 . 8 7 ± 1 5 . 0 8 5 0 . 9 3 ± 1 3 . 6 6 3 9 . 8 1 ± 1 0 . 8 2 0.002
Body mass index 2 6 . 6 1 ± 0 . 9 9 2 4 . 2 5 ± 1 . 1 8 2 4 . 1 3 ± 1 . 1 8 2 4 . 0 5 ± 1 . 0 3 0.23
Sex (male gender, %)61%50%75%81%0.19
Delay 4 , 8 ± 4 . 4 5 . 1 2 ± 6 . 6 6 . 0 ± 6 . 1 7 . 3 ± 8 . 3 0.62
HbA1c 6 . 3 4 ± 0 . 1 8 5 . 9 1 ± 0 . 2 2 5 . 6 1 ± 0 . 2 2 5 . 5 9 ± 0 . 6 5 0.03
HbA1c > 6.5% in treated patients30%6%0%5%0.009
Total cholesterol 4 . 9 6 ± 1 . 1 7 4 . 8 6 ± 1 . 1 0 4 . 7 8 ± 0 . 6 4 4 . 5 8 ± 0 . 7 9 0.61
Triglycerides 1 . 6 4 ± 0 . 6 2 1 . 9 2 ± 0 . 9 7 1 . 9 4 ± 1 . 6 2 1 . 4 6 ± 0 . 6 3 0.39
LDL cholesterol 2 . 5 3 ± 0 . 6 0 2 . 4 9 ± 0 . 8 2 2 . 6 3 ± 0 . 4 2 2 . 3 6 ± 0 . 8 5 0.71
C2 cyclosporine 7 9 6 ± 1 4 6 6 7 3 ± 2 6 0 5 8 6 ± 2 4 5 8 0 ± 2 1 3 0.28
C0 tacrolimus 7 . 3 ± 0 . 6 8 . 4 ± 0 . 7 7 . 6 ± 0 . 7 7 . 7 ± 0 . 6 0.69
BP treatment (Yes)96%80%87%67%0.06